Plavsic Mark 4
4 · FATE THERAPEUTICS INC · Filed Jun 22, 2021
Insider Transaction Report
Form 4
Plavsic Mark
Chief Technical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-14+18,500→ 18,500 totalExercise: $89.97Exp: 2031-06-14→ Common Stock (18,500 underlying) - Award
Common Stock
2021-06-14+38,000→ 38,000 total
Footnotes (2)
- [F1]Exempt grant of restricted stock units pursuant to the Issuer's Inducement Equity Plan. The units will vest in four annual installments after July 1, 2021, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.
- [F2]The option shall vest as to 25% of the underlying shares on June 14, 2022 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.